- Home
- COF vs ABT Comparison
COF vs ABT Comparison
Compare COF & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | COF | ABT |
|---|---|---|
| Founded | 1988 | 1888 |
| Country | United States | United States |
| Employees | 78400 | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 128.2B | 152.9B |
| IPO Year | N/A | 2006 |
Fundamental Metrics
Financial Performance| Metric | COF | ABT |
|---|---|---|
| Price | $218.65 | $107.04 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 20 |
| Target Price | ★ $258.94 | $130.90 |
| AVG Volume (30 Days) | 4.3M | ★ 9.8M |
| Earning Date | 04-21-2026 | 04-16-2026 |
| Dividend Yield | 1.68% | ★ 2.76% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $44,328,000,000.00 |
| Revenue This Year | $95.92 | $10.75 |
| Revenue Next Year | $4.90 | $8.10 |
| P/E Ratio | ★ $52.03 | $173.34 |
| Revenue Growth | N/A | ★ 5.67 |
| 52 Week Low | $174.24 | $81.97 |
| 52 Week High | $259.64 | $137.49 |
Technical Indicators
Market Signals| Indicator | COF | ABT |
|---|---|---|
| Relative Strength Index (RSI) | 65.07 | 68.74 |
| Support Level | $215.83 | $105.27 |
| Resistance Level | $226.57 | $112.81 |
| Average True Range (ATR) | 5.24 | 2.89 |
| MACD | 0.55 | 0.60 |
| Stochastic Oscillator | 99.77 | 86.65 |
Price Performance
Historical ComparisonAbout COF Capital One Financial Corporation
Capital One Financial is a diversified financial-services holding company headquartered in McLean, Virginia. Originally a spinoff of Signet Financial's credit card division in 1994, the company is now primarily involved in credit card lending, auto loans, and commercial lending. Following the acquisition of Discover in 2025, the firm also has a modest personal loan business, though credit card lending provides the majority of the bank's revenue.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.